24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publication dates

Gene Therapy Industry, January 2015 Market Reports from Top Publishers

You might be interested in: medical equipment, cancer, therapeutics, hospital, biotech, drug delivery, epilepsy, heart failure, hemophilia, regenerative medicine, angina, angina pectoris, arteriosclerosis, atherosclerosis, bladder cancer.


 
1-10 of 51 reports for Gene Therapy

Gene Therapy in Oncology Drug Pipeline Update 2015

Gene Therapy in Oncology Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

There are today 122 companies plus partners developing 100 gene therapy drugs in 280 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs ...

MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... In the fields of regenerative medicine and gene therapy. The company provides therapies for autologous and heterologous transplants. Molmed is headquartered in milano, italy.Molmed s.P.A. Key recent ...

Protokinetix Inc. (Symbol:PKTX) SWOT Analysis, Strategy, Revenues and Profits

Protokinetix Inc. (Symbol:PKTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Takara Bio Inc. (Symbol:4974) SWOT Analysis, Strategy, Revenues and Profits

Takara Bio Inc. (Symbol:4974) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Biotechnology research reagents and equipment. It operates through three business divisions, such as bio-industry, gene therapy, and agribio. Its bio-industry division offers sale of a gene amplification system ...

VITA 34 International AG (V3V) - Financial and Strategic SWOT Analysis Review

VITA 34 International AG (V3V) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... On umbilical cord blood, which is used in acquired hearing loss, early childhood brain damage, aplastic anemia, blood cancer, solid tumors, type 1 diabetes, and gene therapy for severe immune deficiency ...

Zeltia, S.A. (ZEL) - Financial and Strategic SWOT Analysis Review

Zeltia, S.A. (ZEL) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Zeltia, S.A. (Zeltia) is a pharmaceutical holding company. It operates through a group of companies in biopharmaceutical and chemical sectors. Under biopharmaceutical sector it discovers and develops ...

Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review

Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... To the patient. The company has a strategic collaboration with celgene corporation to discover, develop and commercialize disease-altering gene therapy products in oncology. It was formerly known as genetix ...

Gene Therapy Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape

Gene Therapy Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape

  • $ 15 000
  • Industry report
  • January 2015
  • by Delve Insight

... Opportunities. The gene therapy report provides the gene therapy targets which are close to 190 with the target gene name, localization of gene, molecular function of target with descriptive mechanism of action ...

Gene Therapy Oncology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Gene Therapy Oncology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

  • $ 3 500
  • Industry report
  • January 2015
  • by Delve Insight

... gene therapy oncology insight: pipeline assessment, market trend, technology and competitive landscape summarydelveinsight's report: gene therapy oncology insight: pipeline assessment ...

Gene Therapy Central Nervous System Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Gene Therapy Central Nervous System Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

  • $ 3 000
  • Industry report
  • January 2015
  • by Delve Insight

... gene therapy central nervous system insight: pipeline assessment, market trend, technology and competitive landscape summarydelveinsight's report: gene therapy central nervous system ...

About 500 reports for Gene Therapy

Download Unlimited Documents from Trusted Public Sources

Takara Bio Annual Report 2014

  • January 2014
    38 pages
  • Japan  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.